| In millions, except per share items | Dec-21-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Medical office buildings | 11.0 | 11.3 | 3.0 | |
| Seniors housing — operating properties | 2.7 | 2.9 | 1.0 | |
| Triple-net leased healthcare facilities | 0.4 | 0.4 | 0.1 | |
| Total revenues [+] | 14.1 | 14.6 | 4.1 | 0.0 |
| Tenant reimbursements | 2.6 | 2.7 | 0.6 | |
| Lease / rental | 8.9 | 9.1 | 2.5 | |
| Revenue growth [+] | -3.3% | 252.9% | | |
| Medical office buildings | -2.5% | 281.9% | | |
| Seniors housing — operating properties | -6.6% | 179.4% | | |
| Triple-net leased healthcare facilities | -2.9% | 184.4% | | |
| Cost of goods sold [+] | 5.4 | 5.3 | 1.4 | 0.0 |
| Related party costs | 0.1 | 0.0 | 0.0 | |
| Real estate or leased property costs | 5.4 | 5.3 | 1.4 | |
| Gross profit | 8.7 | 9.3 | 2.7 | 0.0 |
| Gross margin | 61.5% | 63.8% | 65.8% | |
| Selling, general and administrative [+] | 2.6 | 1.9 | 1.3 | 0.2 |
| General and administrative | 2.6 | 1.9 | 1.3 | 0.2 |
| EBITDA [+] | 6.3 | 7.6 | 1.4 | |
| EBITDA growth | -17.4% | 429.4% | -900.6% | |
| EBITDA margin | 44.6% | 52.2% | 34.8% | |
| Depreciation | 5.1 | 6.0 | 1.7 | |
| EBITA | 1.2 | 1.7 | -0.3 | -0.2 |
| EBITA margin | 8.6% | 11.3% | -7.1% | |
| Amortization of intangibles | 0.2 | 0.2 | 0.0 | |
| EBIT [+] | 1.0 | 1.4 | -0.3 | -0.2 |
| EBIT growth | -30.2% | -545.5% | 80.6% | |
| EBIT margin | 7.1% | 9.9% | -7.8% | |
| Non-recurring items | 2.1 | 0.4 | 4.7 | |
| Interest expense | 0.2 | 0.2 | 0.1 | |
| Interest expense | 0.2 | 0.2 | 0.1 | |
| Other income (expense), net | 0.0 | 0.0 | | |
| Pre-tax income | -1.3 | 0.9 | -5.1 | -0.2 |
| Income taxes | -0.1 | 0.1 | 0.1 | 0.0 |
| Tax rate | 4.4% | 16.4% | | 0.0% |
| Minority interest | 0.0 | 0.0 | 0.0 | |
| Net income | -1.2 | 0.7 | -5.2 | -0.2 |
| Net margin | -8.7% | 5.1% | -125.9% | |
| |
| Basic EPS [+] | ($0.18) | $0.11 | ($1.56) | ($22.68) |
| Growth | -263.1% | -106.9% | -93.1% | |
| Diluted EPS [+] | ($0.18) | $0.11 | ($1.56) | ($22.68) |
| Growth | -263.2% | -106.9% | -93.1% | |
| |
| Dividends per share [+] | $0.91 | $1.56 | $1.25 | |
| Growth | -41.7% | 24.8% | | |
| |
| Shares outstanding (basic) [+] | 6.9 | 6.9 | 3.3 | 0.0 |
| Growth | 1.0% | 105.8% | 42034.2% | |
| Shares outstanding (diluted) [+] | 6.9 | 6.9 | 3.3 | 0.0 |
| Growth | 0.9% | 106.0% | 42034.2% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |